All conventional immunosuppressive tree drugs-protocols are based on Cyclosporine; consisting of low doses of Cyclosporine (CsA), Azathioprine (AZA) or Mycophenolate Mofetil (MMF) and Prednisolone. AZA has been used in clinical transplantation for more than years and was the fi rst immunosuppres-sive agent to achieve widespread use in organ transplantation. MMF was introduced in clinical practice in after several clinical trials proved that it was more effi cient than AZA for prevention of acute rejection episodes. Our aim was to evaluate infl uence of AZA and MMF on renal graft function in early post-transplant stage. Study recruited patients who underwent kidney transplantation in University Clinical Centre Tuzla. All patients recei...
BACKGROUND: The use of mycophenolate mofetil (MMF) is associated with less acute rejection than azat...
Modern immunosuppressive regimens reduce the acute rejection rate by combining a cornerstone immunos...
Modern immunosuppressive regimens reduce the acute rejection rate by combining a cornerstone immunos...
All conventional immunosuppressive tree drugs-protocols are based on Cyclosporine; consisting of low...
Long-term follow-up examination to test whether therapy with mycophenolate mofetil (MMF) or azathiop...
Background. In the first year after renal allograft transplantation, triple therapy immunosuppressio...
Background. The search for more effective and less toxic immunosuppressive agents to control transpl...
Objective. The aim of this study was to compare the graft survival after kidney transplantation in p...
The Mycophenolate Steroids Sparing (MYSS) study found that in renal transplant recipients who were o...
To assess the effect of cyclosporine therapy on the rate of renal function recovery after renal tran...
BACKGROUND: Several multinational controlled clinical trials have shown that triple therapy immunosu...
Background. This study determined whether cyclosporine A (CsA)-treated renal allograft recipients wi...
BackgroundThree large-scale clinical trials conducted in North America, Europe, and Australia showed...
It is unknown whether the addition of mycophenolate mofetil (MMF) to cyclosporine (CsA) and predniso...
Cyclosporine (CsA) is the current primary immunosuppressant for the prevention of renal allograft re...
BACKGROUND: The use of mycophenolate mofetil (MMF) is associated with less acute rejection than azat...
Modern immunosuppressive regimens reduce the acute rejection rate by combining a cornerstone immunos...
Modern immunosuppressive regimens reduce the acute rejection rate by combining a cornerstone immunos...
All conventional immunosuppressive tree drugs-protocols are based on Cyclosporine; consisting of low...
Long-term follow-up examination to test whether therapy with mycophenolate mofetil (MMF) or azathiop...
Background. In the first year after renal allograft transplantation, triple therapy immunosuppressio...
Background. The search for more effective and less toxic immunosuppressive agents to control transpl...
Objective. The aim of this study was to compare the graft survival after kidney transplantation in p...
The Mycophenolate Steroids Sparing (MYSS) study found that in renal transplant recipients who were o...
To assess the effect of cyclosporine therapy on the rate of renal function recovery after renal tran...
BACKGROUND: Several multinational controlled clinical trials have shown that triple therapy immunosu...
Background. This study determined whether cyclosporine A (CsA)-treated renal allograft recipients wi...
BackgroundThree large-scale clinical trials conducted in North America, Europe, and Australia showed...
It is unknown whether the addition of mycophenolate mofetil (MMF) to cyclosporine (CsA) and predniso...
Cyclosporine (CsA) is the current primary immunosuppressant for the prevention of renal allograft re...
BACKGROUND: The use of mycophenolate mofetil (MMF) is associated with less acute rejection than azat...
Modern immunosuppressive regimens reduce the acute rejection rate by combining a cornerstone immunos...
Modern immunosuppressive regimens reduce the acute rejection rate by combining a cornerstone immunos...